Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00074087
Status:
COMPLETED
Last Update Posted:
2018-07-09
First Post:
2003-12-10
Brief Title:
Liposomal Doxorubicin in Treating Patients With Stage IIB Stage IVA or Stage IVB Recurrent or Refractory Mycosis Fungoides
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| recurrent cutaneous T-cell non-Hodgkin lymphoma | View |
| stage II mycosis fungoidesSezary syndrome | View |
| stage IV mycosis fungoidesSezary syndrome | View |
| recurrent mycosis fungoidesSezary syndrome | View |
| stage IV cutaneous T-cell non-Hodgkin lymphoma | View |
| stage II cutaneous T-cell non-Hodgkin lymphoma | View |